First, driver oncogenic mutations are more common in hemogenic vascular malformations (GNAQ, PI3 kinase, tie-2, Braf, and ras) than in lymphatic vascular lesions [20,21,22,23,24]. The gene discussed is BRAF; the disease is vascular malformation.